OMOP Concept 801096

Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Non-standardDrugHCPCSQ2054HCPCS

Maps from

Descendants

Valid from

1 Oct 2021

Valid to

31 Dec 2099

OMOP concepts

Concept Lookup Tool

Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.

Or try

Diabetes Hypertension Aspirin

Maps to standard concept

The OMOP standard concept this code normalizes to via the Maps to relationship — this is what you store in the CDM.

lisocabtagene maraleucel Injection [Breyanzi]StandardRxNorm2479143

Synonyms

Alternative names recorded for Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose across source vocabularies.

Lisocabtagene mara car pos t

Get this concept via the API

Resolve Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.

curl "https://api.omophub.com/v1/concepts/801096?include_relationships=true" \
  -H "Authorization: Bearer $OMOPHUB_API_KEY"

Get your free API key3,000 calls/month free · no credit card